ArticleG3 (Bethesda, Md.)2026
Syrah: a pipeline to maximize spatial transcriptomics data output.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Spatial analysis of gene expression patterns has been a key technique for revealing the potential functions of genes. Traditionally, these analyses, conducted using in situ hybridizations and other labor-intensive protocols, were constrained to examining only a few candidate genes per sample. However, the advent of spatial transcriptomic techniques like Slide-seqV2 has transformed this field, enabling massively parallel exploration of gene expression patterns within their tissue contexts by pairing spatial locations with RNA sequencing. Despite its potential, Slide-seqV2 datasets often produce fewer usable reads than expected. We have identified that a significant source of errors in the technology stems from the chemical synthesis of barcodes used in Slide-seqV2. These errors are systematic, and in many cases, they can be bioinformatically identified and corrected. We have developed "Syrah," an analysis pipeline that identifies and corrects barcode errors in Slide-SeqV2 and Curio seeker datasets. Syrah can dramatically enhance read numbers in Slide-seqV2 datasets, recovering up to 35% more reads, reassigning erroneous barcode matches, and removing improperly formed reads. Unlike other dataset improvement methods that rely on data-driven imputation, Syrah uses a biochemical model and the barcode sequence data and does not require additional datasets or intricate calculations. This innovative technique promises to transform the utility of Slide-seqV2 and Curio Seeker datasets by identifying usable reads that were discarded during previous analysis that required exact matching of barcode sequences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.